Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Lymphoma

  Free Subscription


6 Blood
1 BMC Cancer
1 Bone Marrow Transplant
6 Br J Haematol
1 Cancer
1 Clin Med Insights Oncol
1 Haematologica
1 Leuk Lymphoma
2 Leukemia
1 Nat Rev Cancer
1 Neurology
1 Oncogene
1 Oncology (Williston Park)
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. JIANG W, Zhou X, Li Z, Liu K, et al
    Prolyl 4-Hydroxylase 2 Promotes B-cell Lymphoma Progression via Hydroxylation of Carabin.
    Blood. 2018 Feb 1. pii: blood-2017-07-794875. doi: 10.1182/blood-2017-07-794875.
    PubMed     Text format     Abstract available

  2. Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800-1808.
    Blood. 2018;131:587-588.
    PubMed     Text format    

  3. COTTEREAU AS, Versari A, Loft A, Casasnovas O, et al
    Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial.
    Blood. 2018 Feb 1. pii: blood-2017-07-795476. doi: 10.1182/blood-2017-07-795476.
    PubMed     Text format     Abstract available

  4. SEHN LH, Soulier J
    Introduction to the review series on T-cell malignancies.
    Blood. 2017;129:1059-1060.
    PubMed     Text format    

  5. COURTOIS L, Sujobert P
    Morphologic features of mu-heavy-chain disease.
    Blood. 2017;130:558.
    PubMed     Text format    

  6. TESSON B, Huet S, Grange B, Jallades L, et al
    Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.
    Blood. 2017;130:1267-1269.
    PubMed     Text format    

    BMC Cancer

  7. THOMAS SK, Cha SC, Smith DL, Kim KH, et al
    Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
    BMC Cancer. 2018;18:187.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  8. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    PubMed     Text format    

    Br J Haematol

  9. CHAN KL, Blombery P, Jones K, Lade S, et al
    Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.
    Br J Haematol. 2017;177:324-328.
    PubMed     Text format    

  10. RADESKI D, Montanari F, Alobeid B, O'Connor OA, et al
    Post-transplant lymphoproliferative disorder: a heterogeneous conundrum - response to Weisenburger DD & Gross TG.
    Br J Haematol. 2017;179:856-857.
    PubMed     Text format    

  11. ADAMS HJ, Kwee TC
    Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
    Br J Haematol. 2017;177:319-320.
    PubMed     Text format    

  12. BISHTON MJ, McMillan AK, Fox CP
    Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee.
    Br J Haematol. 2017;177:320-321.
    PubMed     Text format    

    Post-transplant lymphoproliferative disorder: a heterogeneous conundrum.
    Br J Haematol. 2017;179:854-856.
    PubMed     Text format    

  14. DEMARIA L, Henry J, Seror R, Frenzel L, et al
    Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjogren syndrome (pSS).
    Br J Haematol. 2018 Feb 9. doi: 10.1111/bjh.15120.
    PubMed     Text format    


  15. SUREDA A, Zhang MJ, Dreger P, Carreras J, et al
    Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Cancer. 2018 Feb 9. doi: 10.1002/cncr.31264.
    PubMed     Text format     Abstract available

    Clin Med Insights Oncol

  16. FITZGERALD TJ, Bishop-Jodoin M
    Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.
    Clin Med Insights Oncol. 2018;12:1179554918754885.
    PubMed     Text format     Abstract available


  17. SCHOMMERS P, Gillor D, Hentrich M, Wyen C, et al
    Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.
    Haematologica. 2018 Feb 8. pii: haematol.2017.180893.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  18. STECCO A, Buemi F, Iannessi A, Carriero A, et al
    Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Leuk Lymphoma. 2018 Feb 12:1-11. doi: 10.1080/10428194.2018.1434881.
    PubMed     Text format     Abstract available


  19. GONDEK LP, Zheng G, Ghiaur G, DeZern AE, et al
    Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.
    Leukemia. 2016 Mar 15. doi: 10.1038/leu.2016.
    PubMed     Text format     Abstract available

  20. NAIRISMAGI M-, Gerritsen ME, Li ZM, Wijaya GC, et al
    Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma.
    Leukemia. 2018 Feb 2. pii: 10.1038/s41375-017-0004.
    PubMed     Text format     Abstract available

    Nat Rev Cancer

  21. HUET S, Sujobert P, Salles G
    From genetics to the clinic: a translational perspective on follicular lymphoma.
    Nat Rev Cancer. 2018 Feb 9. pii: nrc.2017.127. doi: 10.1038/nrc.2017.
    PubMed     Text format     Abstract available


  22. SALVARANI C, Brown RD Jr, Christianson TJH, Huston J 3rd, et al
    Primary central nervous system vasculitis associated with lymphoma.
    Neurology. 2018 Feb 2. pii: WNL.0000000000005062.
    PubMed     Text format     Abstract available


  23. DEBERNARDI J, Hollville E, Lipinski M, Wiels J, et al
    Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.
    Oncogene. 2018 Feb 14. pii: 10.1038/s41388-018-0123.
    PubMed     Text format     Abstract available

    Oncology (Williston Park)

  24. LUKAS RV, Stupp R, Gondi V, Raizer JJ, et al
    Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
    Oncology (Williston Park). 2018;32.
    PubMed     Text format     Abstract available

    PLoS One

  25. KANG KW, Lee SR, Kim DS, Yu ES, et al
    Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma.
    PLoS One. 2018;13:e0192656.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.